[ad_1]
Image: MGNonline.com
On Thursday, Teva Pharmaceuticals announced the recall of additional losartan tablets due to a risk of cancer.
Losartan is commonly used to treat high blood pressure and the same impurity as previously mentioned, N-methylnitrosobutyric acid, has been discovered in this series of tablets.
Although Teva has not received any reports of adverse effects related to cancer risk, the company has indicated that this risk may occur after prolonged use of the tablets.
The tablets concerned include:
- Losartan potassium 25 mg tablets, light green in color, film-coated, drop-shaped, with "LK 25" on one side and ">" on the other
- Losartan potassium 100 mg tablets, dark green, film-coated, oval shaped, with the inscription "LK 100" on one side and ">" on the other
The tablets were sold to Golden State Medical Supply, which was then packaged and sold under the Golden State brand.
The FDA recommends that patients taking the tablets continue to take them and contact their pharmacist, doctor or health care provider. The agency added that the risk of harming the patient's health is probably higher if the drug is stopped abruptly.
Medical issues, adverse reactions or quality issues of affected products should be directed to Teva Medical Information by e-mail at [email protected] or by phone at (888) 838 -2872, option 3, then option 4. Operators are available to take calls live from 9am to 5pm Monday to Friday, with voicemail available at any time.
The FDA has stated that adverse events or other problems should also be reported online to the FDA's MedWatch adverse event notification program, or by calling (800) 332-1088 to request a form. The form must be completed and returned to the address indicated on the pre-addressed form or faxed to (800) FDA-1088.
For a complete list of recalled lots and return instructions, click here.
[ad_2]
Source link